Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
EVMN · NYSE · Pharmaceutical Preparations
Evommune (EVMN) · oqro.io/stocks/EVMN · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$7.04−0.20 (−2.76%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 16, 2026
T. Rowe Price Associates, Inc. cut its EVMN stake below 5% (2.3%)Source5%+ stake, activist · Stake as of Nov 6, 2026 · Filed Nov 10, 2026
RA Capital Management, L.P. disclosed a 8.5% stake in EVMN and may seek to influence the companySourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Eventide Asset Management, LLC disclosed an increased position in EVMN for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Ra Capital Management, L.P. disclosed an increased position in EVMN for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
RTW Investments, LP disclosed an increased position in EVMN for Q1 2026SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Ra Capital Management, L.P. disclosed a new position in EVMN for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Eventide Asset Management, LLC disclosed a new position in EVMN for Q4 2025Source